Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Recruiting
- Conditions
- Chronic Hepatitis BNonalcoholic Fatty Liver Disease
- Registration Number
- NCT02863757
- Lead Sponsor
- Humanity and Health Research Centre
- Brief Summary
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Liver biopsy proved CHB and/or NAFLD at baseline;
- Chinese
- Follow-up duration>12 months
Exclusion Criteria
- Other liver diseases;
- Secondary causes of hepatic steatosis;
- Alcohol abuse;
- Liver cirrhosis, cirrhosis related complications or HCC at baseline;
- Malignancy;
- History of liver transplantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients with liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma Up to 20 years
- Secondary Outcome Measures
Name Time Method Number of patients with liver transplantation and liver-related death Up to 20 years Number of patients with hypertension, obesity, diabetes mellitus, hyperlipidaemia Up to 20 years Diagnosis time of liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma from baseline Up to 20 years Occurrence time of liver transplantation and liver-related death from baseline Up to 20 years
Trial Locations
- Locations (1)
Humanity and Health GI and Liver Centre
🇨🇳Hong Kong, Hong Kong, China